All Stories

  1. CD44v, S1PR1, HER3, MET and cancer‐associated amino acid transporters are promising targets for the pancreatic cancers characterized using mAb

    Article • FEBS Open Bio, January 2025, Wiley

    Takashi Masuko

  2. Complete Cure of Inoperable Stage IV Locally Advanced Hypopharyngeal Squamous Cell Carcinoma by an Innovative Combination Cancer Immunotherapy Consisting of Radiation, Immune Checkpoint Inhibitors, and Dendritic Cell Vaccine

    Article • Cureus, September 2024, Springer Science + Business Media

    Takashi Masuko

  3. HER4 and EGFR Activate Cell Signaling in NRG1 Fusion-Driven Cancers: Implications for HER2-HER3-specific Versus Pan-HER Targeting Strategies

    Article • Journal of Thoracic Oncology, September 2023, Elsevier

    Takashi Masuko

  4. CD98 regulates the phosphorylation of HER2 and a bispecific anti‐HER2/CD98 antibody inhibits the growth signal of human breast cancer cells

    Article • Genes to Cells, March 2023, Wiley

    Takashi Masuko

  5. Dual‐targeting therapy against HER3/MET in human colorectal cancers

    Article • Cancer Medicine, February 2023, Wiley

    Takashi Masuko

  6. In Vitro Tumor Cell-Binding Assay to Select High-Binding Antibody and Predict Therapy Response for Personalized 64Cu-Intraperitoneal Radioimmunotherapy against Peritoneal Dissemination of Pancreatic Cancer: A Feasibility Study

    Article • International Journal of Molecular Sciences, May 2022, MDPI AG

    Takashi Masuko

  7. Altered binding avidities and improved growth inhibitory effects of novel anti-HER3 mAb against human cancers in the presence of HER1-or HER2-targeted drugs

    Article • Biochemical and Biophysical Research Communications, October 2021, Elsevier

    Takashi Masuko

  8. Oncogenic transformation of NIH/3T3 cells by the overexpression of L-type amino acid transporter 1, a promising anti-cancer target

    Article • Oncotarget, June 2021, Impact Journals, LLC

    Takashi Masuko

  9. Antitumor effects of novel mAbs against cationic amino acid transporter 1 (CAT1) on human CRC with amplified CAT1 gene

    Article • Cancer Science, December 2020, Wiley

    Takashi Masuko

  10. Novel functional anti-HER3 monoclonal antibodies with potent anti-cancer effects on various human epithelial cancers

    Article • Oncotarget, January 2020, Impact Journals, LLC

    Takashi Masuko

  11. Anti‐tumor effects of an antagonistic mAb against the ASCT2 amino acid transporter onKRAS‐mutated human colorectal cancer cells

    Article • Cancer Medicine, November 2019, Wiley

    Takashi Masuko

  12. Glutaminolysis‐related genes determine sensitivity to xCT‐targeted therapy in head and neck squamous cell carcinoma

    Article • Cancer Science, September 2019, Wiley

    Takashi Masuko

  13. Anti‐tumor effects of mAb against l ‐type amino acid transporter 1 ( LAT 1) bound to human and monkey LAT 1 with dual avidity modes

    Article • Cancer Science, January 2019, Wiley

    Takashi Masuko

  14. Inhibition of tumor formation and metastasis by a monoclonal antibody against lymphatic vessel endothelial hyaluronan receptor 1

    Article • Cancer Science, August 2018, Wiley

    Takashi Masuko

  15. Identification of ACA-28, a 1′-acetoxychavicol acetate analogue compound, as a novel modulator of ERK MAPK signaling, which preferentially kills human melanoma cells

    Article • Genes to Cells, May 2017, Wiley

    Takashi Masuko